Bosutinib Tablet, Film Coated
Product Images NDC 62332-312

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Bosutinib (NDC 62332-312). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

120 Tablets (Bosutinib 100)

This text appears to be a label for a medication called Bosutinib. It contains important information such as storage conditions (20°C), permitted excursions (10-15°C and 30°C), prescription details, the manufacturer (Aombic Pharmaceuticals Limited), dosage (100 mg), and warnings against crushing the tablets. Additionally, it includes the NDC number, manufacturing information, and other identifiers. The text also mentions that the medication is for oncology use only.*

FDA Label Image

30 Tablets (Bosutinib 500)

This is a prescription information for Bosutinib Tablets, containing 500mg of bosutinib. It is manufactured by Alembic Pharmaceuticals Limited in India. The package contains 30 tablets and should only be used for oncology purposes. The recommended dosage and further prescribing information can be found in the accompanying documentation. The tablets must not be handled roughly or crushed. The NDC (National Drug Code) for the product is 62332-312-30.*

FDA Label Image

Bosutinib-structure.jpg (Bosutinib Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.